Evolent Health Debt-to-Equity Ratio Growth & History (EVH)

Evolent Health's debt-to-equity ratio was 2.38 for fiscal 2025.

View full Evolent Health company overview

Evolent Health annual debt-to-equity ratio history

Evolent Health annual debt-to-equity ratio

Fiscal yearPeriod endedDebt-to-equity ratioChangeGrowth
20252025-12-312.381.67+234.43%
20242024-12-310.710.11+18.03%
20232023-12-310.600.05+9.01%
20222022-12-310.550.15+37.01%
20212021-12-310.40−0.18−30.37%
20202020-12-310.580.18+46.28%
20192019-12-310.400.20+105.42%
20182018-12-310.190.07+60.92%
20172017-12-310.12−0.05−29.86%
20162016-12-310.170.17
20152015-12-310.00

Evolent Health debt-to-equity ratio trends

Over the last five fiscal years, Evolent Health's debt-to-equity ratio increased from 0.58 to 2.38, a change of 1.80. The latest reported quarter, Q2 2026, shows 2.53.

About the metric

What the debt-to-equity ratio means

The debt-to-equity ratio compares interest-bearing debt with shareholders’ equity. It helps show how much debt financing a company uses relative to its accounting equity, but useful comparison levels vary by industry.

Calculation and source

How debt-to-equity is calculated

TickerStat calculates debt-to-equity as total interest-bearing debt divided by SEC-reported shareholders’ equity for the same balance-sheet date. Total liabilities are not treated as debt, and periods with non-positive equity are omitted. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review Evolent Health source filings ↗

Community posts

It’s quiet here.

No posts about EVH yet. Start the conversation.

Write the first post